CLSA analyst Kunal Lakhan downgraded Dr Lal PathLabs Ltd (DLPL:IN) from Outperform (2) to Hold (3) with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE